A new installment of RGX skins arriving soon can complete your VALORANT collection. Here's everything you need to know. Is this leaked bundle the real deal? New images purport to show VALORANT's ...

CA February 3-7, 2025. The following presentations include an encore of the topline results from the pivotal phase of the Phase I/II/III CAMPSIITE ® trial of RGX-121. Abstract Title: Audiology ...

In a patient aged 7 years old, RGX-202 microdystrophin expression was measured to be 31.5% compared to control. The company said that as of Feb. 21, RGX-202 was well tolerated with no serious ...

REGENXBIO (NASDAQ:RGNX) announced on Monday the closure of a non-dilutive, limited recourse royalty bond agreement of up to ...

ABBV-RGX-314 is being investigated as a potential ... a decline in vision with reduced frequency of treatment over time.7 Diabetic retinopathy (DR) is the leading cause of vision loss in adults ...

Patients under 4 years old have no access to gene therapy, and REGENXBIO is the only gene therapy sponsor recruiting patients in this age group in the U.S. In a patient aged 7 years old ...

At the time, I spoke about the ongoing program using RGX-202 for the treatment of patients with Duchenne Muscular Dystrophy [DMD]. I noted that the company had released positive interim results ...

FDA assigns PDUFA target action date of November 9, 2025 RGX-121 on track to be the first gene therapy and one-time treatment for MPS II Partner Nippon Shinyaku to lead commercialization upon ...

CASTLE ROCK, CO, UNITED STATES, April 17, 2025 /EINPresswire.com/ -- Recycle Global Exchange (RGX), a Colorado-based leader in sustainable IT asset disposition (ITAD ...